Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid Absorption01:24

Lipid Absorption

493
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
493
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

556
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
556

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America.

Journal of clinical lipidology·2024
Same author

Lipid-lowering in diabetes: An update.

Atherosclerosis·2023
Same author

Serum amyloid A and metabolic disease: evidence for a critical role in chronic inflammatory conditions.

Frontiers in cardiovascular medicine·2023
Same author

Recent advances in lipidology.

Best practice & research. Clinical endocrinology & metabolism·2023
Same author

Hypertriglyceridemia.

Endocrinology and metabolism clinics of North America·2022
Same author

Update on Lipids and Lipoproteins.

Endocrinology and metabolism clinics of North America·2022
Same journal

EDITORIAL INTRODUCTION.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Exploring the role of parathyroid hormone in sarcopenia: A review.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Normocalcemic primary hyperparathyroidism: an update on diagnostic and management challenges.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Prediabetes before pregnancy: implications for risk stratification and research.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Secondary hyperparathyroidism in chronic kidney disease: update on pathophysiology and new treatment targets.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Revisiting the relationship between weight loss and bone health in people living with obesity: insights from the latest evidence.

Current opinion in endocrinology, diabetes, and obesity·2026
See all related articles

Related Experiment Video

Updated: Jul 10, 2025

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion
06:14

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion

Published on: November 30, 2022

2.6K

Multifactorial chylomicronemia syndrome.

Alan Chait1

  • 1Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, USA.

Current Opinion in Endocrinology, Diabetes, and Obesity
|November 23, 2023
PubMed
Summary
This summary is machine-generated.

Multifactorial chylomicronemia syndrome (MFCS) involves severely elevated triglycerides, often due to genetic factors and secondary causes. Effective management, including lifestyle changes and medications, can prevent pancreatitis and reduce cardiovascular risk.

More Related Videos

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.3K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.0K

Related Experiment Videos

Last Updated: Jul 10, 2025

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion
06:14

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion

Published on: November 30, 2022

2.6K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.3K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.0K

Area of Science:

  • Cardiology
  • Genetics
  • Metabolic Disorders

Background:

  • Multifactorial chylomicronemia syndrome (MFCS) is characterized by severely elevated plasma triglyceride levels.
  • It arises from the interplay of common genetic hypertriglyceridemia predispositions with secondary triggers or triglyceride-raising medications.
  • Distinguishing MFCS from the rarer familial chylomicronemia syndrome is crucial due to differing treatment strategies.

Conclusions:

  • MFCS management requires addressing both genetic and secondary contributors to hypertriglyceridemia.
  • Reducing triglyceride levels through targeted interventions is key to preventing pancreatitis.
  • Comprehensive management, including lifestyle modifications and pharmacotherapy, is essential for mitigating cardiovascular disease risk in MFCS patients.